755
Views
6
CrossRef citations to date
0
Altmetric
Respiratory

Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study

ORCID Icon, , , , , & show all
Pages 28-36 | Received 09 Jun 2016, Accepted 08 Aug 2016, Published online: 26 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yanhui Wang, Jian Ren, Zhiqing Yao, Wei Wang, Siyang Wang, Junfang Duan, Zhen Li, Huizi Zhang, Ruiqin Zhang & Xiaoru Wang. (2023) Clinical Impact and Risk Factors of Intensive Care Unit-Acquired Nosocomial Infection: A Propensity Score-Matching Study from 2018 to 2020 in a Teaching Hospital in China. Infection and Drug Resistance 16, pages 569-579.
Read now

Articles from other publishers (5)

Joseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell & Zhiwei Gao. (2022) Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap. Respiratory Research 23:1.
Crossref
Dave Singh, James F. Donohue, Isabelle H. Boucot, Neil C. Barnes, Chris Compton & Fernando J. Martinez. (2021) Future concepts in bronchodilation for COPD: dual- versus monotherapy . European Respiratory Review 30:160, pages 210023.
Crossref
F. Maltais, I. P. Naya, C. F. Vogelmeier, I. H. Boucot, P. W. Jones, L. Bjermer, L. Tombs, C. Compton, D. A. Lipson & E. M. Kerwin. (2020) Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial. Respiratory Research 21:1.
Crossref
Ian Naya, Lee Tombs, David A. Lipson, Isabelle Boucot & Chris Compton. (2019) Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis. Respiratory Research 20:1.
Crossref
Ian P. Naya, Lee Tombs, David A. Lipson & Chris Compton. (2018) Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis. Advances in Therapy 35:10, pages 1626-1638.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.